I have begin to think, Charlie Rose is compromised by the people in Mountain View......
He has 23withoutSergey on the TV and here's Anne, blabbing about how amazing and important Factor V Leiden testing is and how "Wouldn't You Like to Know you were at risk Charlie?"
This just days after AHRQ released there report saying that when it comes to blood clots, this test is basically not indicated and not useful......
In addition, and what I may have failed to mention is Anne blabbing about how we need a good way to cohort patients, give them test results and follow up surveys online.
She basically was reading from the informed consent methods section of Coriell's Personalized Medicine Collaborative............
Which leads me to believe that Mike Christman has had it right all along..........Evaluate the science behind each SNP, give it away for FREE and release information that you wish to study.....which is why I was surprised 23andSergey didn't give their hobbled service out for FREE!!! Like TruGenetics is doing....
If there is one thing going on here, it is that 23andSergey is slow on the research uptake. Heck, Navi made this leap immediately after they heard about Coriell......They piled on Eric Topol and started the Scripps study.......
But alas, Navi was a little slow on the clinical side.....I say this because they are now "releasing" the results of 5 other conditions.........What's on the list? You gessed it. Factor V Leiden. Didn't they read my post? Come on Dietrich, we talked.......what is going on there???? Also they must not have read the AHRQ or USPSTF reports on HFE testing either, because that is not recommended either..... These should be studied, not SOLD!
The Sherpa Says: Don't trust Charlie on Genomics, I think he's in the tank for DTC.....
Friday, July 10, 2009
Sergey wants to be Coriell and Navi didn't read AHRQ
Posted by Steve Murphy MD at 6:16 AM
Labels: 23 and me, deCODEme, dietrich stephan, dnadirect, Helix Health of Connecticut, kari stefansson, navigenics, ryan phelan
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment